PharmTech News

Articles

The decision is part of the Takeda’s goal to divest $10 billion in non-core assets and focus on its key business areas.

Takeda to Divest OTC Products to Orifarm for $670 Million

Through the agreement, BARDA will support the advancement of the vaccine candidate to FDA licensure and will handle all late-stage clinical development programs, as well as the scale-up of mRNA-1273 manufacture in 2020.

BARDA Awards Moderna up to $483 Million for COVID-19 Vaccine Candidate Acceleration

The companies announced they are entering into a strategic collaboration under which Blackstone will provide up to $2 billion to fund Alnylam’s RNAi drugs to treat a range of diseases.

Alnylam Pharmaceuticals and Blackstone Life Sciences Enter into Collaboration for up to $2 Billion

The company closed two new funds, ARCH Venture Fund X and ARCH Venture Fund X Overage, for a total of $1.46 billion combined.

Arch Venture Partners to Invest $1.46 Billion in Early Stage Biotechnology Companies

GE biopharma brands are now part of Cytiva, a Danaher Corporation Life Sciences company.

GE Healthcare Life Sciences is Now Cytiva

The partnership will focus on the development of up to five novel protein replacement and mRNA therapies.

Takeda and Evox Enter into a Rare Disease-Focused Partnership for $882 Million

Johnson & Johnson announces clinical trial plans for COVID-19 vaccine candidate, as well as plans to produce 1 billion vaccine doses. 

J&J Ramps Up COVID-19 Vaccine R&D

Noting traditional clinical trials for COVID-19 convalescent plasma will take time, FDA is allowing physicians to submit requests for single-patient emergency INDs. 

FDA Defines Criteria for COVID-19 Convalescent Plasma Treatments

Thermo Fisher is focused on investing to expand three specific areas of demand: biologics, cell and gene therapy, and drug product development and commercial capabilities.

Thermo Fisher Scientific Invests $800 Million into New Capabilities and Capacity

An NIH study of a COVID-19 vaccine is enrolling Seattle-based healthy adult volunteers.

Top News